Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
44.55 USD | -0.36% | +2.02% | -13.17% |
05-15 | US FDA approves expanded use of Bristol's cancer cell therapy | RE |
05-13 | Transcript : Bristol-Myers Squibb Company Presents at Guggenheim Securities Radiopharmaceuticals Day, May-13-2024 11:00 AM |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.17% | 90.63B | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Morgan Stanley Cuts Price Target on Bristol-Myers Squibb to $50 From $56, Says Lower Medium-Term Guidance Raises Questions on 2030 Targets, Keeps Underweight Rating